Karuna Therapeutics Inc

This committee provides the technical analysis and 'scoring' for all tax legislation, directly influencing corporate tax structures, R&D credits, and the overall tax burden, which impacts KRTX's financial performance.

This committee controls taxation, trade, and entitlement spending (Medicare/Medicaid). These policies significantly influence corporate profitability, drug pricing, and market access for pharmaceutical companies like KRTX.

This committee directly allocates federal funds to agencies like the NIH (research funding), FDA (regulatory oversight), and VA (drug procurement), which are vital revenue and operational factors for KRTX.

This committee has direct oversight of the FDA (drug approvals) and NIH (research funding), which are absolutely critical for a pharmaceutical manufacturing company's existence and future pipeline.

This committee's oversight of antitrust laws directly impacts potential mergers and acquisitions in the pharmaceutical sector, and its jurisdiction over intellectual property (patents) is foundational to a drug company's business model.

This committee frequently investigates drug pricing and healthcare for older Americans, a critical market segment and a major policy focus for pharmaceutical companies, creating significant political and headline risk.